GEODE CAPITAL MANAGEMENT, LLC - ELEVEN BIOTHERAPEUTICS INC ownership

ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 26 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ELEVEN BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2018$59,000
+31.1%
56,2220.0%0.00%
Q4 2017$45,000
-48.9%
56,2220.0%0.00%
Q3 2017$88,0000.0%56,2220.0%0.00%
Q2 2017$88,000
-14.6%
56,222
+19.1%
0.00%
Q1 2017$103,000
+15.7%
47,187
+0.6%
0.00%
Q4 2016$89,000
-31.5%
46,887
+0.4%
0.00%
Q3 2016$130,000
+68.8%
46,687
+0.1%
0.00%
Q2 2016$77,000
+450.0%
46,6370.0%0.00%
Q1 2016$14,000
-90.0%
46,637
-0.1%
0.00%
Q4 2015$140,000
+25.0%
46,687
+0.2%
0.00%
Q3 2015$112,000
-14.5%
46,587
+0.2%
0.00%
Q2 2015$131,000
-62.4%
46,487
+18.8%
0.00%
Q1 2015$348,000
-5.2%
39,125
+26.4%
0.00%
Q4 2014$367,000
+7.0%
30,960
+0.5%
0.00%
Q3 2014$343,000
+9.6%
30,810
+29.5%
0.00%
Q2 2014$313,000
-10.6%
23,791
+10.1%
0.00%
Q1 2014$350,00021,6170.00%
Other shareholders
ELEVEN BIOTHERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Flagship Ventures 2007 General Partner LLC 1,907,008$21,244,00014.99%
Third Rock Ventures, LLC 4,841,591$53,935,0006.29%
Broadfin Capital, LLC 857,715$9,555,0001.00%
NJ State Employees Deferred Compensation Plan 25,000$278,0000.06%
SECTORAL ASSET MANAGEMENT INC 112,485$1,253,0000.05%
C WorldWide Group Holding A/S 100,000$1,161,0000.02%
Tower Research Capital LLC (TRC) 9,921$111,0000.01%
SABBY MANAGEMENT, LLC 19,997$223,0000.01%
Ground Swell Capital, LLC 402$4,0000.01%
Point72 Asset Management, L.P. 55,450$618,0000.01%
View complete list of ELEVEN BIOTHERAPEUTICS INC shareholders